Replies to post #1041 on Rich Pharmaceuticals Inc. (fka RCHA)

[MR.METICULOUS]

SHANGHAI , Jan. 9, 2015 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that it has updated its 2014 financial guidance. The company expects to achieve total revenues for full-year 2014 of approximately $674 million, compared to previous guidance of $670-672 million. The company expects to achieve diluted EPS of approximately $1.87 (non-GAAP) and approximately $1.56 (GAAP), compared to previous guidance of 1.83-1.86 (non-GAAP) and $1.55-1.58 (GAAP).

[was GoldenDD]

that is where the partnership comes in with big pharmas..

[Helter Skelter]

It isn't... > "Great points - we'll see what happens - clinical Phase 3 trials cost $MILLIONS - where is that money going to come from? -"

Link... > That's why there's 37.5 billion AS = not enough

[Crazy Money]

lol the AS is 40 BILLION :-)